Propranolol as the first-line therapy for infantile hemangiomas: Preliminary results of two centers

Basit Öğe Kaydı
dc.contributor.authorCelik A.
dc.contributor.authorTiryaki S.
dc.contributor.authorMusayev A.
dc.contributor.authorKismali E.
dc.contributor.authorLevent E.
dc.contributor.authorErgun O.
dc.date.accessioned2019-10-26T21:47:18Z
dc.date.available2019-10-26T21:47:18Z
dc.date.issued2012
dc.departmentEge Üniversitesien_US
dc.description.abstractAim: Despite a mostly self-limiting course, infantile hemangiomas can cause severe functional and/or cosmetic problems. The aim of this study was to determine the efficiency of propranolol treatment on infantile hemangiomas. Methods: Sixty-seven infantile hemangioma patients were included in propranolol protocol in two institutions from 2009 to 2011. Participants included 36 boys and 31 girls. An associate protocol with radiology and pediatric cardiology was constructed for appropriate patient selection. Patients received a dose of 2 mg/kg/day, and all were admitted for the first 24 hours of therapy. Results: Sixty-seven patients were included in the study. Mean age at the initiation of therapy was 7 months (1 to 24 months), and eleven patients were older than 12 months of age when propranolol was started. All patients showed improvement with varying responses. No side effects were detected during the treatment. Conclusion: Previously defined treatments for hemangiomas were efficient, yet had a limited usage because of side effects. Propranolol, with a high efficacy (not as total involution but stabilization and regression) and feasibility deserves to be the first line therapy for infantile hemangiomas even after the proliferation phase. Copyright © 2012 Journal of Drugs in Dermatology.en_US
dc.identifier.endpage811en_US
dc.identifier.issn1545-9616
dc.identifier.issue7en_US
dc.identifier.pmid22777220en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage808en_US
dc.identifier.urihttps://hdl.handle.net/11454/18601
dc.identifier.volume11en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofJournal of Drugs in Dermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePropranolol as the first-line therapy for infantile hemangiomas: Preliminary results of two centersen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu